R21CA102123/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: R21CA102123/CA/NCI NIH HHS/United States[Grants a - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2006	1
2009	1
2025	0

2 results

Page of 1

Results by year

Page 1

Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.

Cai W, Chen X. Cai W, et al. Anticancer Agents Med Chem. 2006 Sep;6(5):407-28. doi: 10.2174/187152006778226530. Anticancer Agents Med Chem. 2006. PMID: 17017851 Review.

Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.

Liu Z, Yan Y, Chin FT, Wang F, Chen X. Liu Z, et al. J Med Chem. 2009 Jan 22;52(2):425-32. doi: 10.1021/jm801285t. J Med Chem. 2009. PMID: 19113865

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year